Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment

the PSOGI

doi:10.1016/j.ejso.2020.02.012

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment

the PSOGI

Department of Surgery

Research output: Contribution to journal › Article

Abstract

Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled trials on treatment strategies are lacking, nor likely to be performed in the foreseeable future. However, many questions regarding the management of appendiceal tumours, especially when accompanied by PMP, remain unanswered. This consensus statement was initiated by members of the Peritoneal Surface Oncology Group International (PSOGI) Executive Committee as part of a global advisory role in the management of uncommon peritoneal malignancies. The manuscript concerns an overview and analysis of the literature on mucinous appendiceal tumours with, or without, PMP. Recommendations are provided based on three Delphi voting rounds with GRADE-based questions amongst a panel of 80 worldwide PMP experts.

Original language	English (US)
Journal	European Journal of Surgical Oncology
DOIs	https://doi.org/10.1016/j.ejso.2020.02.012
State	Accepted/In press - 2020

All Science Journal Classification (ASJC) codes

Surgery
Oncology

Access to Document

10.1016/j.ejso.2020.02.012

Fingerprint Dive into the research topics of 'Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment'. Together they form a unique fingerprint.

Cite this

the PSOGI (Accepted/In press). Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2020.02.012

@article{5dc27418c039457d8ea7b63b97d3bb91,

title = "Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment",

abstract = "Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled trials on treatment strategies are lacking, nor likely to be performed in the foreseeable future. However, many questions regarding the management of appendiceal tumours, especially when accompanied by PMP, remain unanswered. This consensus statement was initiated by members of the Peritoneal Surface Oncology Group International (PSOGI) Executive Committee as part of a global advisory role in the management of uncommon peritoneal malignancies. The manuscript concerns an overview and analysis of the literature on mucinous appendiceal tumours with, or without, PMP. Recommendations are provided based on three Delphi voting rounds with GRADE-based questions amongst a panel of 80 worldwide PMP experts.",

author = "{the PSOGI} and K. Govaerts and Lurvink, {R. J.} and {De Hingh}, {I. H.J.T.} and {Van der Speeten}, K. and L. Villeneuve and S. Kusamura and V. Kepenekian and M. Deraco and O. Glehen and Moran, {B. J.} and Pedro Barrios-Sanchez and Baumgartner, {Joel M.} and Almog Ben-Yaacov and Rosella Bertulli and Peter Cashin and Tom Cecil and Sanjeev Dayal and {De Simone}, Michele and Foster, {Jason M.} and Diane Goere and Kuno Lehmann and Yan Li and Loggie, {Brian W.} and Faheez Mohamed and Morris, {David L.} and Aviram Nissan and Pompiliu Piso and Marc Pocard and Beate Rau and Reymond, {Marc A.} and Lucas Sideris and Spiliotis, {John D.} and Sugarbaker, {Paul H.} and Verwaal, {Victor J.} and Wilson, {Malcom S.} and Yutaka Yonemura and Yang Yu",

year = "2020",

doi = "10.1016/j.ejso.2020.02.012",

language = "English (US)",

journal = "European Journal of Surgical Oncology",

issn = "0748-7983",

publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Appendiceal tumours and pseudomyxoma peritonei

T2 - Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment

AU - the PSOGI

AU - Govaerts, K.

AU - Lurvink, R. J.

AU - De Hingh, I. H.J.T.

AU - Van der Speeten, K.

AU - Villeneuve, L.

AU - Kusamura, S.

AU - Kepenekian, V.

AU - Deraco, M.

AU - Glehen, O.

AU - Moran, B. J.

AU - Barrios-Sanchez, Pedro

AU - Baumgartner, Joel M.

AU - Ben-Yaacov, Almog

AU - Bertulli, Rosella

AU - Cashin, Peter

AU - Cecil, Tom

AU - Dayal, Sanjeev

AU - De Simone, Michele

AU - Foster, Jason M.

AU - Goere, Diane

AU - Lehmann, Kuno

AU - Li, Yan

AU - Loggie, Brian W.

AU - Mohamed, Faheez

AU - Morris, David L.

AU - Nissan, Aviram

AU - Piso, Pompiliu

AU - Pocard, Marc

AU - Rau, Beate

AU - Reymond, Marc A.

AU - Sideris, Lucas

AU - Spiliotis, John D.

AU - Sugarbaker, Paul H.

AU - Verwaal, Victor J.

AU - Wilson, Malcom S.

AU - Yonemura, Yutaka

AU - Yu, Yang

PY - 2020

Y1 - 2020

N2 - Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled trials on treatment strategies are lacking, nor likely to be performed in the foreseeable future. However, many questions regarding the management of appendiceal tumours, especially when accompanied by PMP, remain unanswered. This consensus statement was initiated by members of the Peritoneal Surface Oncology Group International (PSOGI) Executive Committee as part of a global advisory role in the management of uncommon peritoneal malignancies. The manuscript concerns an overview and analysis of the literature on mucinous appendiceal tumours with, or without, PMP. Recommendations are provided based on three Delphi voting rounds with GRADE-based questions amongst a panel of 80 worldwide PMP experts.

AB - Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled trials on treatment strategies are lacking, nor likely to be performed in the foreseeable future. However, many questions regarding the management of appendiceal tumours, especially when accompanied by PMP, remain unanswered. This consensus statement was initiated by members of the Peritoneal Surface Oncology Group International (PSOGI) Executive Committee as part of a global advisory role in the management of uncommon peritoneal malignancies. The manuscript concerns an overview and analysis of the literature on mucinous appendiceal tumours with, or without, PMP. Recommendations are provided based on three Delphi voting rounds with GRADE-based questions amongst a panel of 80 worldwide PMP experts.

UR - http://www.scopus.com/inward/record.url?scp=85081946729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081946729&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2020.02.012

DO - 10.1016/j.ejso.2020.02.012

M3 - Article

AN - SCOPUS:85081946729

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

ER -